SightfileU.S. market data from official filings

Companies › LCTX

LINEAGE CELL THERAPEUTICS IN (LCTX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000876343 · EDGAR filings · Updated 2026-07-02

LINEAGE CELL THERAPEUTICS IN (LCTX) has reported institutional ownership of 44.8%, with 131 institutional managers holding positions valued at $176.5M per the latest 13F reporting period.

Institutional ownership
44.8%
Institutional managers
131
Reported 13F value
$176.5M
Insider activity
9 trans.
$24.4K net buying

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, LINEAGE CELL THERAPEUTICS IN has 131 institutional holders and institutional ownership of 44.8%.

Insider activity

Insiders reported 9 transactions (1 buys, 0 sells) across 2 reporting insiders, with a net reported value of $24.4K.

Related companies

USANA HEALTH SCIENCES INC (USNA) · ANIKA THERAPEUTICS INC (ANIK) · ABEONA THERAPEUTICS INC (ABEO) · CAMP4 THERAPEUTICS CORP (CAMP) · ORASURE TECHNOLOGIES INC (OSUR) · PULSE BIOSCIENCES INC (PLSE)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.